H02.735
Vitiligo of left lower eyelid and periocular area
Clinical Classification Guidelines
Medical Intelligence & Overview
Vitiligo of the left lower eyelid and periocular area is a skin condition characterized by the loss of pigment, resulting in white patches in the skin around the eye. This condition affects the skin's melanin-producing cells, leading to distinctive depigmentation. Although it can develop anywhere on the body, its occurrence around the eyes is particularly noticeable and can influence both appearance and emotional well-being.
Causes & Symptoms
Clinical Causes: Autoimmune response where the body's immune system attacks melanin-producing cells in the skin. Genetic predisposition, with a family history of vitiligo or other autoimmune conditions. Environmental factors such as exposure to certain chemicals or skin trauma that may trigger or worsen the condition. Neurochemical factors that affect melanocyte function. Stress or emotional upheaval potentially contributing to immune dysregulation.
Key Symptoms: Localized depigmented patches of skin around the left lower eyelid and periocular area. Smooth, chalky-white patches that are usually well-defined. Patches that may enlarge over time or remain stable. Absence of symptoms like pain or itching in most cases. Potential cosmetic concerns leading to emotional or psychological impact.
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a clinical examination of the affected area to identify characteristic depigmentation. A healthcare provider may also conduct additional tests, such as:
Treatment Protocols: While vitiligo currently has no cure, several treatment options can help improve its appearance or stabilize the skin's condition. These include:
Clinical Advice & FAQs
Billing Guidance
Is H02.735 a billable ICD-10 code?
Yes, H02.735 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H02.735?
Clinical documentation must specify the nature of Vitiligo of left lower eyelid and periocular area and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
